LEAH Labs
YC W19Minneapolis, US · Founded 2018 · 4 employees · 1 known investors
LEAH Labs engineers gene-edited CAR-T cell therapies to treat cancer in pet dogs, with the goal of generating translational insights for human cancer therapy. The company uses proprietary gene editing and protein design to develop therapeutic treatments for companion animal oncology.
AI & Machine LearningBiotechHealthtechMedical DevicesCRISPRCell TherapyDrug discoveryin /company@leahlabsinc
Founders & leadership· Y Combinator alumni (W19)
Wesley Wiersonin𝕏Founder
WA
Wesley A. WiersonFounder & CEO
AM
Alex M. AbelChief Scientific Officer
SC
Stephen C. EkkerScientific Founder & Board Director
SS
Saad S. KenderianScientific Founder
JP
Jonathan P. MochelScientific Founder
Investors · 1
In the news
- LEAH Labs Raises $3 Million in Funding for Groundbreaking Pet Therapiesleadsontrees.com · 2024
- LEAH Labs - 2025 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- LEAH Labs Startup Fetching Fresh Funding for Cancer Treatment for Dogs | Twin Cities Businesstcbmag.com · 2021
- Founder Profile: LEAH Labs - Kingscrowdkingscrowd.com · 2019
- LEAH Labs on Wefunder - Kingscrowdkingscrowd.com · 2019
- LEAH Labs - featured on investibuleinvestibule.co